Networking and Applying to Radiation Oncology During A Pandemic: Cross-Sectional Survey of Medical Student Concerns

We assessed the effectiveness of a digital networking session tailor-made for third- and fourth-year medical college students fascinated about radiation oncology, and report college students’ considerations about making use of to radiation oncology in the course of the pandemic. A multi-institutional networking session was hosted on Zoom and included medical college students, college, and residents from throughout the nation. The breakout room characteristic was used to divide members into smaller teams. Participants had been randomly shuffled into new teams each 10 to 15 minutes. Students accomplished pre- and post-session surveys.

Among the 134 college students who registered, 69 college students participated within the session, and 53 college students accomplished a post-session survey. Most college students reported the session was worthwhile or very worthwhile (79%), and it was straightforward or very straightforward to community via the digital format (66%). After the session, 18 (33.9%) college students reported their curiosity in radiation oncology elevated, and 34 (64.2%) reported their curiosity remained the identical. Most college students believed COVID-19 (55%) and digital interviews and platforms (55%) negatively or considerably negatively affected their means to choose a residency program. Most college students (62%) had been involved they are going to be inaccurately evaluated as an interviewee on a digital platform.

Although 30% agreed or strongly agreed the cost-savings and comfort of digital interviews outweigh potential downsides, 66% of college students had been planning to go to cities of curiosity in particular person earlier than rank checklist submission. Medical college students reported vital considerations with their means to be precisely evaluated and to select amongst residency applications on a digital platform. Students discovered the networking session to be a worthwhile useful resource for many college students, and applications might proceed related efforts in the course of the residency utility cycle to higher signify their program whereas sustaining sure monetary and geographic benefits of a digital surroundings.

Undergraduate nursing applications are required to put together nursing college students to take care of individuals throughout the lifespan, nevertheless due to restricted paediatric nursing content material in undergraduate nursing curricula and restricted paediatric medical placements, nursing graduates could lack competence and expertise in caring for youngsters.

Fireside Chats: A Novel Wellness Initiative for Medical Students within the COVID-19 Era

To complement preexisting wellness programming for the surgical procedure clerkship, a school surgeon at Vanderbilt initiated Fireside Chats (FC) in 2015. Inspired by Franklin Roosevelt’s Depression-era radio broadcasts, FC options small group sizes, off-campus excursions, and a reimagining of the mentor-mentee relationship that eschews hierarchy in favor of deep, mutualistic connections in each private and skilled domains. As conclusion, the general public narrative framework has modified the best way medical college students take into consideration how to mobilize individuals for well being promotion in a college.

Here we describe the rationale and implementation of FC and current survey knowledge that show the nice and cozy reception of FC and its efficacy in stewarding the psychological well being of medical college students. Moreover, not like giant group actions resembling “studying communities,” FC continues to meet in-person throughout COVID-19 and preserves social engagement alternatives that will alleviate pandemic-induced isolation and misery. Narrative approaches are gaining energy as sources of motivation to help the adoption of wholesome behaviors.

A qualitative, inductive content material evaluation was carried out to discover a trainer’s reflections on the experiences of a crew of medical college students utilizing public narratives to promote well being inside a Colombian college. Data had been collected from the trainer’s written reflective journal and an educational report, the latter, submitted by the medical college students. ‘Being mobilized’ emerged as an overarching class. The experiences had been described in three interrelated classes: crew involvement, boundaries and countering these boundaries. In phrases of crew involvement, college students had been motivated, dedicated, related with individuals and pissed off. On the opposite hand, boundaries resembling doubts and discomfort remarked, and lastly these boundaries had been countered via coaching, observe and teamwork.

Networking and Applying to Radiation Oncology During A Pandemic: Cross-Sectional Survey of Medical Student Concerns

The function of emotional competencies in predicting medical college students‘ attitudes in direction of communication abilities coaching

This research goals to examine whether or not stress, melancholy and emotional competencies will help to predict medical college students’ attitudes in direction of communication abilities coaching (CST). Anxiety and damaging attitudes in direction of CST have been proven to be linked. Conversely, emotional competencies (EC) had been related to constructive attitudes. Exploring these psycho(patho)logical variables subsequently appears to be a promising strategy to higher understanding, and even modifying, attitudes in direction of CST.
179 third yr medical college students had been requested to full the Communication Skills Attitude Scale (CSAS), the Perceived Stress Scale (PSS), the Montgomery-Asberg Depression Rating Scale Self-assessment (MADRS-S) and the Profile of Emotional Competence (PEC).  168 college students accomplished your entire questionnaire. The stepwise regression mannequin first revealed that, taken collectively, intrapersonal EC “Utilization” and interpersonal EC “Expression” account for 17% of the variance in constructive attitudes. Secondly, taken collectively, intrapersonal EC “Utilization” and interpersonal EC “Expression” account for 16% of the variance in damaging attitudes.
Compstatin control peptide
B5478-1 1 mg
EUR 373
Neuropeptide Y (scrambled)
B7530-1 1 mg
EUR 405
Description: Scrambled Neuropeptide Y (scNPY) was similarly synthesized and contains the same amino acids as NPY, but scNPY is in a random sequence, it was used as a control in the research in NPY [1]. The sequence of scNPY is SKPQRDANREPTRYAIYDYSNPDIELHYLRPAYALG-NH2 [2].
LL-37 scrambled peptide
HY-P1513 1mg
EUR 349
Scrambled TRAP Fragment Peptide
20-abx265858
  • EUR 356.00
  • EUR 537.00
  • EUR 286.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.
Positive control tissue section for each antibody; Based on availability INQUIRE
Control-Slides Set of 5
EUR 176
Human, mouse, rat connexin 32 hemi-channel-scrambled peptide
Cx3212-PS-1 1 mg
EUR 263
Rac1 Inhibitor F56, control peptide
B5275-1 1 mg
EUR 399
Bax inhibitor peptide, negative control
A4462-1 1 mg
EUR 340
Description: Negative control peptide for the Bax inhibitor peptides V5 and P5 , which inhibit Bax translocation to mitochondria and Bax-mediated apoptosis in vitro.
Human NEP1-40 of Nogo-66 peptide, Scrambled peptide control for NEP140, >95% pure
NEP140-115 100 ug
EUR 286
Human NEP1-40 of Nogo-66 peptide Scrambled peptide control for NEP140 >95% pure
NEP140-115-1000 1000 ug
EUR 773
L201 pLVPTH2- tTR- KRAB- Cerulean- scrambled- shRNA- Control
PVT11122 2 ug
EUR 301
Human, mouse, rat connexin 32 hemi-channel-Scrambled peptide (GAP24 domain)
Cx2410-PS-1 1 mg
EUR 286
Human, mouse, rat connexin 43 hemi-channel-Scrambled peptide (GAP26 domain)
Cx2606-PS-1 1 mg
EUR 286
Human, mouse, rat connexin 43 and 37 scrambled peptide (GAP27 domain)
Cx2704-PS-1 1 mg
EUR 263
Human, mouse, rat connexin 40 hemi-channel-Scrambled peptide (GAP27 domain)
Cx2708-PS-1 1 mg
EUR 263
3-D Life Scrambled RGD Peptide
09-P-003 1 µmol
EUR 121
3-D Life Scrambled RGD Peptide
P11-3 3x 1 µmol
EUR 276
Mouse Lipin-1 Control/blocking peptide control/blocking peptide #1
LPN11-P 100 ug
EUR 164
Human, mouse, rat connexin 37/40 hemi-channel Scrambled peptide (GAP26 domain)
Cx2602-PS-1 1 mg
EUR 286
Scrambled 10Panx
A2701-10 10 mg
EUR 258
Description: Scrambled 10Panx is the scrambled form of 10Panx (WRQAAFVDSY), a mimetic peptide of pannexin 1 that inhibits dye uptake by macrophages without affecting cellular membrane currents.
Scrambled 10Panx
A2701-25 25 mg
EUR 514
Description: Scrambled 10Panx is the scrambled form of 10Panx (WRQAAFVDSY), a mimetic peptide of pannexin 1 that inhibits dye uptake by macrophages without affecting cellular membrane currents.
Scrambled 10Panx
A2701-5 5 mg
EUR 166
Description: Scrambled 10Panx is the scrambled form of 10Panx (WRQAAFVDSY), a mimetic peptide of pannexin 1 that inhibits dye uptake by macrophages without affecting cellular membrane currents.
Mouse Lipin-2 Control/blocking peptide control/blocking peptide #1
LPN21-P 100 ug
EUR 164
Mouse Lipin-3 Control/blocking peptide control/blocking peptide #1
LPN31-P 100 ug
EUR 164
TRAF6 Control Peptide
H-7606.0001 1.0mg
EUR 506
Description: Sum Formula: C139H232N34O42; CAS# [852690-80-3] net
LL-37 (scrambled)
H-7886.0500 0.5mg
EUR 283
Description: Sum Formula: C205H340N60O53; CAS# [1354065-56-7] net
LL-37 (scrambled)
H-7886.1000 1.0mg
EUR 441
Description: Sum Formula: C205H340N60O53; CAS# [1354065-56-7] net
Scrambled TRAP Fragment
5-01910 4 x 5mg Ask for price
Donkey IgG (Control, non-immune, isotype control)
20028-1 1 mg
EUR 164
AH1 peptide (gp70 H2-Ld-restricted epitope) (SPSYVYHQF, >95%) Control/blocking peptide
AH11-P-1 1 mg
EUR 225
Flg15 peptide (deletion peptide 30-44 aa, Flic, P. aeruginosa) control,pure
FLG15-P-1 1 mg
EUR 286
Mouse Peptide YY (PYY) control/blocking peptide # 1
PYY11-P 100 ug
EUR 164
Mouse control serum, CD-1
NMOS-CD1-1 1 ml
EUR 103
Human Aven Control/blocking peptide # 1
AVEN11-P 100 ug
EUR 164
Drosophila BMAL Control/blocking peptide # 1
BMALD11-P 100 ug
EUR 164
Rat EAAT4 Control/blocking peptide #1
EAAT41-P 100 ug
EUR 164
Human EAAT5 Control/blocking peptide #1
EAAT51-P 100 ug
EUR 164
Mouse GPR39 control antigen peptide #1
GPR391-P 100 ug
EUR 164
Human HE2 Control/blocking peptide #1
HE21-P 100 ug
EUR 164
Human Ghrelin control/blocking peptide # 1
GHS11-P 100 ug
EUR 164
Human Galanin Control/blocking peptide # 1
GAL51-P 100 ug
EUR 164
Human CYP26A1 control/blocking peptide #1
CYP26A11-P 100 ug
EUR 164
Mouse Clock Control/blocking peptide # 1
CLO11-P 100 ug
EUR 164
Drosophila Clock Control/blocking peptide # 1
CLO13-P 100 ug
EUR 164
Human MutY Control/blocking peptide #1
MUTY11-P 100 ug
EUR 164
Human NHERF1 Control/blocking peptide #1
NHERF11-P 100 ug
EUR 164
Human NHERF2 Control/blocking peptide #1
NHERF21-P 100 ug
EUR 164
Human Nicastrin control (blocking) peptide #1
NICN11-P 100 ug
EUR 164
Rat Nephrin Control/blocking peptide #1
NPHN11-P 100 ug
EUR 164
Mouse Leptin Control/blocking peptide # 1
OB11-P 100 ug
EUR 164
Human KST1 Control/blocking peptide # 1
KST11-P 100 ug
EUR 164
Mouse Per1 Control/blocking peptide #1
PER11-P 100 ug
EUR 164
Drosophila Per1 Control/blocking peptide # 1
PER14-P 100 ug
EUR 164
Mouse Per2 Control/blocking peptide #1
PER21-P 100 ug
EUR 164
Mouse Per3 Control/blocking peptide #1
PER31-P 100 ug
EUR 164
Human Podocin Control/blocking peptide #1
PODO11-P 100 ug
EUR 164
Human Podocalyxin Control/blocking peptide #1
PODX11-P 100 ug
EUR 164
Human MOP3 Control/blocking peptide #1
MOP31-P 100 ug
EUR 152
Human MOP4 Control/blocking peptide #1
MOP41-P 100 ug
EUR 164
Human Motilin control/blocking peptide # 1
MOTL11-P 100 ug
EUR 164
Rat UT2 Control/blocking peptide #1
RUT21-P 100 ug
EUR 164
Rat Syntenin Control/blocking peptide #1
SDB11-P 100 ug
EUR 164
Human Tankyrase Control/blocking peptide #1
TANK11-P 100 ug
EUR 164
Rat VGLUT1/BNPI control peptide # 1
VGLUT11-P 100 ug
EUR 164
Human VGLUT2/DNPI control peptide # 1
VGLUT21-P 100 ug
EUR 164
Human APOBEC 1 Control/blocking peptide # 1
APOBEC11-P 100 ug
EUR 164
Human Merlin 1 Control/blocking peptide #1
MERL11-P 100 ug
EUR 164
JAG - 1 (188 - 204), Jagged – 1 (188 - 204), Notch Ligand
5-01413 4 x 1mg Ask for price
Amyloid b-Protein (1-42) (scrambled)
H-7406.0500 0.5mg
EUR 441
Description: Sum Formula: C203H311N55O60S; CAS# [1678415-52-5] net
Amyloid b-Protein (1-42) (scrambled)
H-7406.1000 1.0mg
EUR 589
Description: Sum Formula: C203H311N55O60S; CAS# [1678415-52-5] net
Amyloid b-Protein (1-40) (scrambled)
H-7408.0500 0.5mg
EUR 335
Description: Sum Formula: C194H295N53O58S; CAS# [1678415-68-3] net
Amyloid b-Protein (1-40) (scrambled)
H-7408.1000 1.0mg
EUR 606
Description: Sum Formula: C194H295N53O58S; CAS# [1678415-68-3] net
Control Magnetic Beads
M1302-1
EUR 98
Human, mouse, rat connexin 32 hemi-channel-scrambled peptide
Cx3212-PS-5 5 mg
EUR 773
Rat neurofascin (Nfasc)-control Control/blocking peptide
AB-23249-CP 100ug
EUR 164
Llama IgG (Control, non-immune, isotype control, ELISA grade)
20030-1 1 mg
EUR 164
Camel IgG (Control, non-immune, isotype control, ELISA grade)
20031-1 1 mg
EUR 164
Alpaca IgG (Control, non-immune, isotype control, ELISA grade)
20032-1 1 mg
EUR 164
Control/Blocking peptide CD40
CD4011-C 100 ug
EUR 164
Control/Blocking peptide EOMES
EMS11-C 100 ug
EUR 164
Kemptide Negative Control Peptide
20-abx265856
  • EUR 356.00
  • EUR 537.00
  • EUR 286.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.
Mouse VGLUT3 control peptide
VGLUT31-P 100 ug
EUR 164
Human VGLUT3 control peptide
VGLUT32-P 100 ug
EUR 164
Human Gastric inhibitory peptide (GIP) Control/blocking peptide #1
GIP71-P 100 ug
EUR 164
Human Peptide Histidine-Methionine (PHM) Control/blocking peptide #1
PHM11-P 100 ug
EUR 164
Mouse Vasoactive intestinal peptide (VIP) Control/blocking peptide #1
VIP16-P 100 ug
EUR 164
Rat Exchange inhibitory peptide (XIP) Control/blocking peptide #1
XIP11-P 100 ug
EUR 164
Scrambled sgRNA CRISPR Lentivector
K018 1.0 ug
EUR 154
Rat Aquaporin 1 (AQP1) Control/blocking peptide #1
AQP11-P 100 ug
EUR 164
Rat Aquaporin 1 (AQP1) Control/blocking peptide #1
AQP12-P 100 ug
EUR 164
Mouse Cryptochrome 1 (CRY1) Control/blocking peptide # 1
CRY11-P 100 ug
EUR 164
Mouse beta-Defensin 1 control/blocking peptide #1
MBD11-P 100 ug
EUR 164
QVD-OPh Negative Control
1171-1
EUR 207
Custom Neg Control siRNA
M1256-1
EUR 278
Labeled Neg Control siRNA
M1257-1
EUR 311
Custom Pos Control siRNA
M1258-1
EUR 278
miRNA Inhibitor Neg Control
M1266-1
EUR 278
Rat Akt-2 Control/blocking peptide #1
AKT21-P 100 ug
EUR 164
Rat Akt-3 Control/blocking peptide #1
AKT31-P 100 ug
EUR 164
Human Cachectic Factor Control/blocking peptide #1
CACH11-P 100 ug
EUR 164
Human Aquaporin AQPAP Control/blocking peptide # 1
AQPAP11-P 100 ug
EUR 164
Rat AVP V1a Control/blocking peptide # 1
AVP1A11-P 100 ug
EUR 164
Rat Bin 1b Control/blocking peptide #1
BIN1B11-P 100 ug
EUR 164
Beta catenin 1 (CTNNB1) Control/Blocking Peptide
BCTN11-C 100 ug
EUR 164
Rat EAAC1/EAAT3 Control/blocking peptide #1
EAAC11-P 100 ug
EUR 164
Human Glucagon (GLGN) Control/blocking peptide #1
GLGN11-P 100 ug
EUR 164
Human HE2 alpha Control/blocking peptide #1
HE2A11-P 100 ug
EUR 164
Human HE2 beta Control/blocking peptide #1
HE2B21-P 100 ug
EUR 164
Human HE2 gamma Control/blocking peptide #1
HE2G31-P 100 ug
EUR 164
Rat FAS Ligand Control/blocking peptide #1
FASL11-P 100 ug
EUR 164
Human Telomerase/EST2 Control/blocking peptide # 1
EST21-P 100 ug
EUR 164
Mouse pannexin 1 (Panx1) Control/blocking peptide
AB-23016-P 100ug
EUR 164
Human pannexin 1 (Panx1) Control/blocking peptide
AB-23017-P 100ug
EUR 164
Mouse pannexin 1 (Panx1) Control/blocking peptide
AB-23246-P 100ug
EUR 164
Mouse pannexin 1 (Panx1) Control/blocking peptide
AB-23247-P 100ug
EUR 164
Rat DRASIC/ASIC3 Control/blocking peptide #1
DRASIC31-P 100 ug
EUR 164
Rat Dopamine Transporter Control/blocking peptide # 1
DAT11-P 100 ug
EUR 164
Human CUGBP2/ NAPOR Control/blocking peptide # 1
CUGBP21-P 100 ug
EUR 164
Drosophila Cryptochrome (dCRY) Control/blocking peptide # 1
CRYD13-P 100 ug
EUR 164
Human Motilin/GPR38 control/blocking peptide # 1
MTLR11-P 100 ug
EUR 164
Human Filtrin/NLG1 Control/blocking peptide #1
NLG11-P 100 ug
EUR 164
Human Neuroligin 1 (NLGN1) Control/blocking peptide
NLGN11-P 100 ug
EUR 164
Human Neurotensin (NT) Control/blocking peptide # 1
NT61-P 100 ug
EUR 164
Human OB-RGRP Control/blocking peptide # 1
OBRGRP11-P 100 ug
EUR 164
Mouse PiT1 (GLVR1) Control/blocking peptide #1
PIT11-P 100 ug
EUR 164
Rat Proline transporter Control/blocking peptide #1
PROL11-P 100 ug
EUR 164
Mouse Merlin 2 Control/blocking peptide #1
MERL21-P 100 ug
EUR 164
Mouse/Human Mahogany Control/blocking peptide #1
MAHG11-P 100 ug
EUR 164
Rat MDEG2/ASIC2b Control/blocking peptide #1
MDEG21-P 100 ug
EUR 164
Rat/human Oxytocin Control/blocking peptide #1
OT15-P 100 ug
EUR 164
Rat Oxytocin Receptor Control/blocking peptide #1
OTR11-P 100 ug
EUR 164
Mouse Orexin-B Control/blocking peptide # 1
OXB11-P 100 ug
EUR 164
Human Oxyntomodulin (OXM) Control/blocking peptide #1
OXM11-P 100 ug
EUR 164
Human Secretin (SECR) Control/blocking peptide #1
SECR11-P 100 ug
EUR 164
Human Survivin (BIRC5) Control/blocking peptide #1
SURV11-P 100 ug
EUR 164
Human Synuclein-alpha Control/blocking peptide #1
SYN11-P 100 ug
EUR 164
Human Synuclein-Beta Control/blocking peptide #1
SYN13-P 100 ug
EUR 164
Mouse Synuclein-gamma Control/blocking peptide # 1
SYN14-P 100 ug
EUR 164
Human TIE-1 Control/blocking peptide #2
TIE12-P 100 ug
EUR 164
Human TIE-2 Control/blocking peptide #1
TIE21-P 100 ug
EUR 164
Mouse Tubby Protein Control/blocking peptide # 1
TUBBY11-P 100 ug
EUR 164
The extra competent a scholar is in “Utilization” and “Expression”, the extra constructive attitudes and the much less damaging attitudes he/she has in direction of CST. In addition, measuring a big set of bio-psycho-social components is perhaps a approach of capturing extra variance in attitudes in direction of CST. In the research of variables influencing attitudes in direction of CST, emotional competencies can’t be ignored. The context of the medical session encourages the dialogue of numerous feelings felt by the affected person. As educationalists, we must always put together the coed for this by integrating the notion of EC inside the CST.